Hennion & Walsh Asset Management Inc. Acquires 980 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hennion & Walsh Asset Management Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,765 shares of the medical equipment provider’s stock after acquiring an additional 980 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in Intuitive Surgical were worth $3,899,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Norges Bank bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $1,313,238,000. Capital Research Global Investors purchased a new position in Intuitive Surgical in the 1st quarter worth approximately $374,390,000. Assenagon Asset Management S.A. grew its holdings in Intuitive Surgical by 111.7% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,285,565 shares of the medical equipment provider’s stock valued at $513,056,000 after buying an additional 678,375 shares in the last quarter. Coatue Management LLC raised its position in shares of Intuitive Surgical by 65.7% during the fourth quarter. Coatue Management LLC now owns 1,301,595 shares of the medical equipment provider’s stock valued at $439,106,000 after buying an additional 516,054 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after acquiring an additional 493,126 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.7 %

Shares of NASDAQ:ISRG opened at $482.16 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $482.78. The company’s 50 day moving average is $444.48 and its 200 day moving average is $408.57. The company has a market cap of $171.02 billion, a PE ratio of 87.03, a price-to-earnings-growth ratio of 4.97 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter last year, the company posted $1.18 earnings per share. The firm’s revenue was up 14.5% compared to the same quarter last year. Equities research analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have commented on the stock. Morgan Stanley boosted their price target on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Stifel Nicolaus increased their price target on Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a research note on Friday, July 19th. The Goldman Sachs Group assumed coverage on Intuitive Surgical in a research report on Thursday, May 30th. They set a “buy” rating and a $500.00 target price for the company. Robert W. Baird boosted their price target on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research report on Friday, July 19th. Finally, Piper Sandler lifted their price objective on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research note on Friday, July 19th. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $442.30.

Insider Activity

In other Intuitive Surgical news, Director Craig H. Barratt sold 2,496 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Intuitive Surgical news, Director Craig H. Barratt sold 2,496 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $402.89, for a total transaction of $1,005,613.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amal M. Johnson sold 2,943 shares of the firm’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $5,441,507.50. The disclosure for this sale can be found here. Insiders sold a total of 15,309 shares of company stock valued at $6,642,470 in the last quarter. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.